Home About Us Events BioProcess International and Cell & Gene Therapy Manufacturing & Commercialization part of Biotech Week Boston

BioProcess International and Cell & Gene Therapy Manufacturing & Commercialization part of Biotech Week Boston

September 27-30, 2022

Boston, MA

Biotech Week Boston CGT/BPI

FUJIFILM Diosynth is delighted to be sponsoring BioProcess International and Cell & Gene Therapy Manufacturing & Commercialization both part of Biotech Week Boston, September 27-30,2022 at the Boston Convention and Exhibition Center, Boston, MA.

Stop by booth 219 co-located at BPI & CGT or schedule a meeting through the ConnectMe meet with our team to learn more about FUJIFILM Diosynth Biotechnologies’ capabilities and how we can help you advance and deliver tomorrow’s medicines.

Join Our Presentations during Biotech Week Boston

 

September 28, 2022 @ 11:30 am
Ian Goodwin, Director, Viral Gene Therapy Global Program Design, FUJIFILM Diosynth Biotechnologies, College Station, TX is presenting on Strategies to Propel Your Viral Vector Therapy from Lab to Clinic

  • There are a number of challenges drug developers face on the journey to the clinic, including high costs and competitive timelines. FDB has a number of solutions that help our partners navigate the challenges of development and material supply for clinical trials as well as propel their life changing medicines to commercialization. Our solutions include a flexible AAV platform and a wealth of regulatory experience taking medicines to the market for our partners.

Click here for more information

 

September 29, 2022 @ 11:15 am, Room: 210A
Joshua Souther, Senior Scientist, Upstream Development, FUJIFILM Diosynth Biotechnologies, North Carolina is presenting on Single-Use Recovery: Centrifugation and Depth Filtration

  • Clarification of mammalian cell culture processes is performed using disk stack centrifugation or depth filtration, the former requires significant capital expenditure and physical space, while the latter is being challenged with ever increasing cell densities and mAb titers. Recent innovations in single-use centrifugation technologies as well as depth filtration offer promise in alleviating current challenges in biomanufacturing.

 

Click here for more information